| Autor: |
Lustig Y, Canetti M, Indenbaum V, Peretz Y, Weiss-Ottolenghi Y, Margalit I, Asraf K, Levin T, Zuckerman N, Tomer E, Mandelboim M, Doolman R, Barda N, Regev-Yochay G |
| Jazyk: |
angličtina |
| Zdroj: |
Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 1050-1052. |
| DOI: |
10.3201/eid3005.231739 |
| Abstrakt: |
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain-specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
